FCF co-organizes, together with its partner YAFO Capital, the “ACCESS CHINA Forum – Winter Online Partnering Weeks” which will be held online on January 4th-22nd, 2021. ACCESS CHINA is the most effective deal-making platform for
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – 10/2020”. The Monitor is a monthly published overview of biotechnology, pharmaceutical, medical technology and healthcare technology companies,
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF European Infrastructure & Construction Market Study – 2020”. Based on available data from European infrastructure and construction companies, the FCF Infrastructure & Construction
FCF Fox Corporate Finance GmbH is pleased to publish the “FCF Advanced Manufacturing Venture Capital Report – 2020”. The report is part of the “FCF DeepTech Series“, which is a quarterly series of reports tracking
FCF Fox Corporate Finance GmbH advises Immunic on financing the development of a potential COVID-19 drug
Gräfelfing/Munich, October 23rd, 2020 – FCF Fox Corporate Finance acts as advisor to Immunic, a biotechnology company specialized on immunology therapies, in the execution of a venture loan financing with the European Investment Bank (EIB).
FCF Fox Corporate Finance GmbH is pleased to publish the “Robotics Venture Capital Report – 09/2020”. The report is part of the “FCF DeepTech Series”, which is a quarterly series of reports tracking European venture